Editorial
Published on 27 May 2025
Editorial: Potential therapeutic approaches of female hormones in the brain
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1617394
- 396 views
Type at least 3 characters
2,465 articles
Original Research
Published on 27 May 2025
Tetramethylpyrazine enhances neuroprotection and plasticity in cerebral ischemia-reperfusion injury via RhoA/ROCK2 pathway inhibition
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1594283
- 787 views
Review
Published on 26 May 2025
Brain injury biomarkers as targets for drugs development and personalized treatment for traumatic brain injury patients
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1606174
- 633 views
Original Research
Published on 23 May 2025
Therapeutic potential of a rhein-loaded self-nano-emulsifying drug delivery system in ameliorating LPS-induced depression: mechanistic insights and behavioral outcomes
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1577080
- 985 views
Original Research
Published on 22 May 2025
Mangiferin mitigates neurological deficits and ferroptosis via NRF2/ARE pathway activation in cerebral ischemia-reperfusion rats
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1577954
- 1,097 views
Case Report
Published on 21 May 2025
Case Report: Pharmacokinetics of ceftazidime and avibactam during and after CRRT in an elderly patient and their associations with CNS adverse effects
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1569715
- 735 views
Perspective
Published on 20 May 2025
Benzodiazepine use in Spain: risks and perspectives on the current situation and proposals for their rational use
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1547488
- 1,592 views
- 1 citation
Review
Published on 19 May 2025
Post stroke depression: pathogenesis and molecular mechanisms of natural product-based interventions
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1595160
- 1,051 views
Original Research
Published on 16 May 2025
The regulation and mechanism of the cAMP-PKA pathway on PTSD-like behaviors exacerbated by alcohol exposure
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1592187
- 950 views
Original Research
Published on 16 May 2025
Tetramethylpyrazine attenuates the blood-brain barrier damage against ischemic stroke by targeting endothelin-1/Akt pathway in astrocytes
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1571552
- 824 views
Original Research
Published on 15 May 2025
Comparative safety analysis of bevacizumab and alkylating agent in glioblastoma management – What have we learned recently?
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1595642
- 994 views
Original Research
Published on 15 May 2025
Chronic administration of prebiotics and probiotics prevent pathophysiological hallmarks of Alzheimer’s disease in the cortex of APP/PS1 mice
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1596469
- 1,123 views
Original Research
Published on 14 May 2025
A ROS-responsive, aptamer-targeted graphene oxide nanocomposite for site-specific glutathione release in cerebral ischemia-reperfusion injury
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1543870
- 894 views
Original Research
Published on 14 May 2025
Neurological adverse events associated with baclofen: a pharmacovigilance study based on FDA adverse event reporting system
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1569602
- 1,123 views
Original Research
Published on 14 May 2025
Global trends and collaborations in bortezomib-induced neurotoxicity research: a bibliometric analysis (2002–2024)
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1584383
- 862 views
Case Report
Published on 13 May 2025
Case Report: Linezolid-associated toxic optic neuropathy in patients with pulmonary tuberculosis: case series and mini review
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1547236
- 938 views